Repare Therapeutics Inc expected to post a loss of 78 cents a share - Earnings Preview

Repare Therapeutics

01/08/2023 03:05

* Repare Therapeutics Inc  RPTX.OQ   RPTX.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 2
(estimated). 
    * The St-laurent Quebec-based  company is expected to report
 a
1,031.6% increase in revenue to $7.683 million from $679
thousand a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Repare Therapeutics
Inc
is for a loss of 78 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $28​, above​ its last closing price
of $9.20. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.80       -0.81      -0.83     Missed  -2.6
 Dec. 31 2023  -0.70       -0.72      -0.75     Missed  -3.9
 Sep. 30 2022  -0.89       -0.89      1.71      Beat    292.6​
 Jun. 30 2022  -0.84       -0.85      -0.91     Missed  -7.5
 ​​Mar.        -0.86       -0.86      -0.83     Beat    3
 31 2022                                                
 Dec. 31 2021  -0.74       -0.74      -0.70     Beat    5.4​
 Sep. 30 2021  -0.71       -0.71      -0.83     Missed  -16.9
 Jun. 30 2021  -0.60       -0.60      -0.71     Missed  -17.4
 This summary was machine generated August 1 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated